Skip to main content
. 2018 Jan 25;4:JGO.17.00146. doi: 10.1200/JGO.17.00146

Fig 2.

Fig 2

(A) Five-year overall survival and (B) disease-free survival for patients with grade 1 or 2 endometrioid carcinoma versus patients with grade 3 endometrioid carcinoma or nonendometrioid histologies.